Neuromodulation techniques to create a nerve blockage with a combination stimulation/block therapy for glycemic control

US2023355975A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2023355975-A1
Application numberUS-202318131555-A
CountryUS
Kind codeA1
Filing dateApr 6, 2023
Priority dateMay 5, 2022
Publication dateNov 9, 2023
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A system is provided herein for stimulating an anatomical element of a patient to achieve glycemic control for the patient. In some examples, the system may include a device configured to generate a current and an electrode device electrically coupled to the device that includes a plurality of electrodes configured for placement on or around the anatomical element. The device may receive instructions to apply the current to the anatomical element via the plurality of electrodes of the electrode device. Additionally, the current may be applied using a first waveform of a plurality of waveforms that the device is capable of generating, where each of the plurality of waveforms comprise a substantially similar charge density. Additionally or alternatively, a system is provided that provides a pharmacological blockade at the anatomical element using a micropump that is configured to deliver a pharmacological agent to the anatomical element to achieve glycemic control.

First claim

Opening claim text (preview).

What is claimed is: 1 . A system for stimulating an anatomical element of a patient, comprising: an implantable pulse generator configured to generate a current; an electrode device electrically coupled to the implantable pulse generator, the electrode device comprising a plurality of electrodes configured for placement on or around the anatomical element of the patient; a processor; and a memory storing data for processing by the processor, the data, when processed, causes the processor to: transmit instructions to the implantable pulse generator to apply the current generated to the anatomical element of the patient via the plurality of electrodes of the electrode device, wherein the current is applied using a first waveform of a plurality of waveforms that the implantable pulse generator is capable of generating, each of the plurality of waveforms comprising a substantially similar charge density. 2 . The system of claim 1 , wherein the anatomical element comprises a celiac vagal trunk and a hepatic vagal trunk of the patient. 3 . The system of claim 2 , wherein the first waveform comprises a frequency between 0.1 and 20 hertz (Hz). 4 . The system of claim 3 , wherein the first waveform comprises a biphasic pulse. 5 . The system of claim 4 , wherein the first waveform comprises a square wave shape, a trapezoidal wave shape, a sinusoidal wave shape, or another wave shape that is charge balanced. 6 . The system of claim 2 , wherein the memory stores further data for processing by the processor that, when processed, causes the processor to: transmit instructions to the implantable pulse generator to increase a frequency, an amplitude, or both of the first waveform incrementally when applying the current. 7 . The system of claim 6 , wherein the frequency, the amplitude, or both of the first waveform are incrementally increased over time to generate a desired shape for the first waveform. 8 . The system of claim 1 , wherein the data stored in the memory that, when processed causes the processor to transmit instructions to the implantable pulse generator to apply the current using the first waveform further causes the system to: transmit instructions to the implantable pulse generator to apply a pattern of stimulation pulses to the anatomical element to simulate a physiological neuron spiking behavior at the anatomical element, wherein the first waveform comprises the pattern of stimulation pulses. 9 . The system of claim 8 , wherein the first waveform comprises a standard shape that is determined based at least in part on a plurality of patient studies, common physiological patterns, or a combination thereof. 10 . The system of claim 8 , wherein the first waveform comprises a shape that is determined based at least in part on observing signaling on the anatomical element at different stages of a metabolic cycle of the patient. 11 . The system of claim 8 , wherein the pattern of stimulation pulses is regular or non-regular. 12 . The system of claim 1 , wherein the memory stores further data for processing by the processor that, when processed, causes the processor to: manipulate a circadian cycle associated with the anatomical element based at least in part on indicating for the implantable pulse generator to apply the current using the first waveform. 13 . The system of claim 12 , wherein the first waveform modulates a first tone of the anatomical element to match a second tone of the anatomical element, the second tone representative of time periods of minimal activity of the patient. 14 . A system for providing a pharmacological blockade at an anatomical element of a patient, comprising: a micropump configured to deliver a pharmacological agent to the anatomical element; a processor; and a memory storing data for processing by the processor, the data, when processed, causes the processor to: transmit instructions to the micropump to deliver the pharmacological agent to the anatomical element via the micropump, wherein the pharmacological agent blocks a physiological response of the anatomical element, the physiological response of the anatomical element comprising an increase in glucose production in the patient. 15 . The system of claim 14 , wherein the anatomical element comprises a hepatic vagal trunk of the patient. 16 . The system of claim 14 , wherein the anatomical element comprises a liver of the patient, receptors on a surface of the liver, or a combination thereof. 17 . The system of claim 16 , wherein the pharmacological agent blocks the liver from producing glucose and stimulates neural pathways of the patient to release glucagon. 18 . The system of claim 16 , wherein the pharmacological agent mimics actions of an insulin hormone or glucagon hormone. 19 . A system for stimulating an anatomical element of a patient, comprising: an implantable pulse generator configured to generate a current; an electrode device comprising: a body; and a plurality of electrodes disposed on the body and configured to apply the current to the anatomical element; a processor; and a memory storing data for processing by the processor, the data, when processed, causes the processor to: transmit instructions to the implantable pulse generator to apply the current generated to the anatomical element of the patient via the plurality of electrodes of the electrode device, wherein the current is applied using a first waveform of a plurality of waveforms that the implantable pulse generator is capable of generating, each of the plurality of waveforms comprising a substantially similar charge density. 20 . The system of claim 19 , wherein the anatomical element comprises a celiac vagal trunk and a hepatic vagal trunk of the patient.

Assignees

Inventors

Classifications

  • using patient feedback · CPC title

  • adapted for vagal stimulation (A61N1/36114 takes precedence) · CPC title

  • specified by the stimulation parameters · CPC title

  • with automatic adjustment · CPC title

  • Determining activity level · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2023355975A1 cover?
A system is provided herein for stimulating an anatomical element of a patient to achieve glycemic control for the patient. In some examples, the system may include a device configured to generate a current and an electrode device electrically coupled to the device that includes a plurality of electrodes configured for placement on or around the anatomical element. The device may receive instru…
Who is the assignee on this patent?
Medtronic Inc
What technology area does this patent fall under?
Primary CPC classification A61N1/36053. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Nov 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).